EPISODE · Feb 5, 2025 · 45 MIN
249. Neuro: A New Low-Profile Intracranial Device Platform with Jesse Christopher, CEO, Longeviti Neuro Solutions
from State of Medtech · host State of Medtech
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.00:00 Exploring the Frontiers of Neurosurgery03:00 Jesse Christopher's Journey to Longevity Neurosolutions05:46 Innovating in Neurosurgery: The Birth of Longevity08:56 The ClearFit Platform: A New Era in Diagnostics12:04 Transforming Patient Care with Real-Time Imaging15:09 The Future of Neurosurgery: Collaboration and Innovation23:50 Understanding Adverse Events in Healthcare24:50 The Economic Impact of Bedside Ultrasound25:47 Innovations in Imaging Technology26:58 Investment Opportunities in Medical Technology28:12 The Future of Ultrasound in Diagnostics30:00 Real-Time Imaging and Patient Mobility32:06 Telehealth and Remote Monitoring Innovations33:39 Economic Viability and Innovation in Healthcare34:38 Research and Outcomes in Neurosurgery39:11 AI and Data Capture in HealthcareFor limited time only - Get the Medical Sales Network Effects Program for 60% off https://salesnetworkeffectsprogram.mykajabi.com/offers/FV2MG8sK?coupon_code=PODCAST2024Follow The State of MedTech on:LinkedInInstagramTikTokXFacebookFollow Omar M. Khateeb onLinkedInInstagramTikTokXFacebook
NOW PLAYING
249. Neuro: A New Low-Profile Intracranial Device Platform with Jesse Christopher, CEO, Longeviti Neuro Solutions
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m